Fundz

Zenii, Llc reported raising in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEApr 12, 2018$0 of $2M raised

Round Type

Venture

New YorkBiotechnologyHealth Care

Quick answer

Intrommune Therapeutics, Inc. raised an undisclosed amount in a funding round, dated April 12, 2018. Intrommune Therapeutics, Inc. is based in New York, New York, United States.

How much did Intrommune Therapeutics, Inc. raise?
Intrommune Therapeutics, Inc. raised an undisclosed amount in a funding round on April 12, 2018.
What does Intrommune Therapeutics, Inc. do?
Intrommune Therapeutics is a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies.
Where is Intrommune Therapeutics, Inc. based and how big is it?
Intrommune Therapeutics, Inc. is based in New York, New York, United States.
Who are the decision-makers at Intrommune Therapeutics, Inc?
Fundz holds 1 contact at Intrommune Therapeutics, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Intrommune Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Grail raised $300M on May 25, 2018.
  • Niki BioSolutions, Inc. raised $1.6M (Seed) on May 25, 2018.
  • Shattuck Labs, Inc. raised $47M on May 25, 2018.
  • Acasti raised $373K on May 25, 2018.
  • Kerecis raised $1.5M (Seed) on May 24, 2018.
  • Scipher Medicine raised $795K (Seed) on May 24, 2018.

Who to call at Intrommune Therapeutics, Inc., and when

A new round usually means Intrommune Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Intrommune Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Intrommune Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Intrommune Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Intrommune Therapeutics, Inc.

Location

20 W 125TH ST. UNIT #1

New York, New York, United States

About

Intrommune Therapeutics is a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Intrommune Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMichael N., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Intrommune Therapeutics, Inc.'s next move

See what Strategic adds

Intrommune Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.